锂中毒后SILENT的预测:多中心队列研究与实用风险分层模型
这项回顾性国际多中心队列纳入2015—2022年西班牙、爱尔兰、瑞士23家三级医院中评估锂中毒的成人644例次,SILENT定义为60天时记录的归因于锂毒性的持续性神经后遗症。49例(7.6%)发生SILENT,患者年龄更大、更多为急性-on-慢性中毒、有早期神经表现且临床严重度更高;血锂浓度与SILENT无关。基于年龄、中毒类型、神经系统表现(共济失调/肌阵挛)、中毒严重度评分和尿素峰值的模型区分度良好(AUC 0.813,95%CI 0.743-0.882),内部验证可接受(AUC 0.730,95%CI 0.572-0.888);敏感性导向阈值(P≥0.0475)阴性预测值达98.2%,支持用于优先安排出院后神经随访,但实施前需外部验证。
要点
- 锂中毒后SILENT并非罕见结局,644例次中49例(7.6%)在60天时记录到归因于锂毒性的持续性神经后遗症。
- 血清锂浓度与SILENT无关联,不能仅凭血锂水平预测长期神经后遗症。
- 预测模型纳入年龄、中毒类型、神经系统表现(共济失调/肌阵挛)、中毒严重度评分和尿素峰值,AUC 0.813(95%CI 0.743-0.882)。
- 敏感性导向阈值P≥0.0475的阴性预测值为98.2%,可用于识别不太可能发生SILENT者以优先安排出院后神经随访。
- 该模型需外部验证后方可临床实施,当前不能作为决策阈值使用。
适用人群与场景
- 2015—2022年在西班牙、爱尔兰、瑞士23家三级医院中评估锂中毒的成人患者,共644例次。
- SILENT患者更常见于年龄更大、急性-on-慢性中毒、有早期神经表现和临床严重度更高者。
诊断标准与关键阈值
- SILENT定义为60天时记录的归因于锂毒性的持续性神经后遗症。
- 预测模型变量:年龄、中毒类型、神经系统表现(共济失调/肌阵挛)、中毒严重度评分、尿素峰值。
- 敏感性导向阈值P≥0.0475,阴性预测值98.2%。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 早期出现神经系统表现(共济失调/肌阵挛)的锂中毒患者SILENT风险更高,需警惕并安排出院后神经随访。
- 急性-on-慢性中毒、年龄较大、临床严重度更高(中毒严重度评分高)及尿素峰值高者SILENT风险更高。
研究设计与关键结果
- 研究类型:回顾性、国际、多中心队列研究,纳入23家三级医院644例次锂中毒评估。
- 主要终点:SILENT在49例(7.6%)中发生;预测概率可用于456例次(其中39例SILENT)。
- 血清锂浓度与SILENT无关联。
- 模型区分度:AUC 0.813(95%CI 0.743-0.882);内部 split-sample 验证AUC 0.730(95%CI 0.572-0.888)。
- 敏感性导向阈值P≥0.0475的阴性预测值为98.2%。
证据类型、等级与局限
- 证据类型:回顾性多中心队列研究。
- 局限:回顾性设计、需外部验证后方可实施;原文未报告证据等级或推荐强度。
对床旁实践的改变
- 锂中毒后不能仅凭血清锂浓度判断长期神经预后,应结合年龄、中毒类型、早期神经表现、中毒严重度评分和尿素峰值进行风险分层。
- 对模型预测概率低于P≥0.0475阈值者,阴性预测值98.2%,可优先安排出院后神经随访;但该阈值尚未经外部验证,不能作为常规决策阈值。
- SILENT发生率7.6%高于既往个案报道提示,应提高对锂中毒后持续性神经后遗症的警觉。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: The Syndrome of Irreversible Lithium-Effectuated Neurotoxicity (SILENT) is a rare but potentially devastating complication of lithium poisoning. Current evidence rests on case reports and small series, leaving its true incidence, risk factors, and follow-up tools poorly defined.
METHODS: Retrospective, international, multicenter cohort of adults evaluated for lithium poisoning (2015-2022) across 23 tertiary hospitals in Spain, Ireland, and Switzerland. SILENT was defined as persistent neurological sequelae attributed to lithium toxicity documented at 60 days. A parsimonious multivariable logistic regression model was built from routinely available clinical variables and assessed by ROC analysis and internal split-sample validation.
RESULTS: Among 644 episodes, SILENT was identified in 49 (7.6%); predicted probabilities were available for 456 episodes (39 SILENT cases). Affected patients were older and more often had acute-on-chronic poisoning, early neurological manifestations, and greater clinical severity. Serum lithium concentrations were not associated with SILENT. The model-age, poisoning type, neurological findings (ataxia/myoclonus), Poisoning Severity Score, and peak urea-showed good discrimination (AUC 0.813; 95% CI 0.743-0.882) and acceptable internal validation (AUC 0.730; 95% CI 0.572-0.888). A sensitivity-oriented threshold (P≥0.0475) yielded a high negative predictive value (98.2%), supporting its use to prioritize post-discharge neurological follow-up.
DISCUSSION: SILENT occurred more frequently than case-based literature suggests and followed a recognizable presentation pattern. Serum lithium alone did not predict long-term sequelae. The model, based on routine variables, may offer a pragmatic tool for early risk stratification.
CONCLUSION: SILENT is not an exceptional outcome after lithium poisoning and cannot be predicted by serum lithium alone. A simple clinical prediction model may identify patients warranting structured neurological follow-up. External validation is required before implementation.
参考来源
- Pineda-Torcuato Á, Caballero-Bermejo AF, Supervia A, et al. Predicting SILENT after lithium poisoning: a multicenter cohort study and pragmatic risk stratification model. Clin Toxicol (Phila). 2026. PMID: 42703744. doi:10.1080/15563650.2026.2693677
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。